This agreement will expand the market for G21 and at the same time we will have the possibility to create awareness of our coming product, the soft cement.
We are very happy about this agreement and look forward to the launch of our soft cement.
Inossia receives US FDA Breakthrough Device Designation
Stockholm, July 1, 2025 – Inossia AB is proud to
